Stockscreener 앱 받기
34.25
6.73%
2.16
시간 외 거래:
33.59
-0.66
-1.93%
전일 마감가:
$32.09
열려 있는:
$32.42
하루 거래량:
54,874
Relative Volume:
1.21
시가총액:
$1.50B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+13.90%
1개월 성능:
-7.43%
6개월 성능:
-12.96%
1년 성능:
+0.00%
1일 변동 폭
$32.20
$35.05
1주일 범위
$27.32
$35.45
52주 변동 폭
$5.60
$55.65
Anbio Biotechnology Stock (NNNN) Company Profile
NNNN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NNNN
Anbio Biotechnology
|
34.25 | 1.41B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
592.27 | 210.16B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
202.71 | 58.51B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
81.02 | 40.19B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
248.21 | 36.37B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
40.43 | 31.30B | 27.43B | 1.27B | 1.01B | 1.5829 |
Anbio Biotechnology 주식(NNNN)의 최신 뉴스
Anbio Biotechnology falls -5.8% - MSN
Anbio Biotechnology (NASDAQ:NNNN) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - simplywall.st
Anbio Biotechnology's (NASDAQ:NNNN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? - Yahoo Finance
Anbio Biotechnology Posts Higher Margins and Profits Despite Revenue Dip in First Half of 2025 - The Globe and Mail
Anbio Biotechnology | 6-K: Report of foreign private issuer (related to financial reporting) - 富途牛牛
Anbio Biotechnology Reports Earnings Results for the Half Year Ended June 30, 2025 - marketscreener.com
Why Anbio Biotechnology Class A Shares Are Sliding - TipRanks
Why Anbio Biotechnology Class A Shares Keep Sliding - TipRanks
Year-End Review | The 2025 US IPO Gainers List is Out! Anbio Biotechnology Soars Over 570%, 'First Stablecoin Stock' Circle Surges More Than 180% - 富途牛牛
Anbio Biotechnology rises 11.2% - MSN
Why Anbio Biotechnology Class A Shares Are Rising - TipRanks
Top US Stock Losers Today (December 10, 2025): Why Polestar, AeroVironment, Aegon and Other Names Are Sinking - ts2.tech
Morning Market Movers: PLRZ, PMI, CBIO, HY See Big Swings - RTTNews
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Anbio Biotechnology (NNNN) Stock Analysis Report | Financials & Insights - Benzinga
Anbio Biotechnology plummets 56% after InvestingPro’s overvalued warning By Investing.com - Investing.com Nigeria
Anbio Biotechnology trading resumes - MSN
Working capital per share of Anbio Biotechnology Class A – DUS:N3B - TradingView
Anbio Biotechnology rises 15.4% - MSN
Anbio Biotechnology Shares Surge Amid Auditor Appointment - TipRanks
Anbio BiotechnologyClass A Ordinary Shares (Nasdaq:NNNN) Stock Quote | Star Tribune - FinancialContent
Anbio Biotechnology Appoints New Auditor - TipRanks
[6-K] Anbio Biotechnology Current Report (Foreign Issuer) | NNNN SEC FilingForm 6-K - Stock Titan
Anbio Biotechnology (N3B.F) latest press releases and corporate news - Yahoo Finance UK
Anbio Biotechnology trading halted, volatility trading pause - MSN
Medtech test developer Anbio files for $9M US IPO - MSN
Why Anbio Biotechnology Class A Stocks Are Tumbling - TipRanks
Anbio Biotechnology Shares on a Wild Ride - TipRanks
Anbio Biotechnology falls -19.5% - MSN
Why Anbio Biotechnology Stock is Tumbling - TipRanks
Anbio Biotechnology (NNNN) Stock Forecast & Price Targets: Today, Tomorrow, Next Week - Traders Union
Anbio Biotechnology (NNNN) Stock Price Today | Live Chart & News - Traders Union
Anbio Biotechnology (NNNN) Stock Price Prediction for 2025, 2026, 2030-2040 - Traders Union
Anbio Biotechnology falls -5.5% - MSN
Anbio Biotechnology falls -26.6% - MSN
Why Anbio Biotechnology’s Stock is Tumbling - TipRanks
Anbio Biotechnology Class A Ordinary Shares 7-Year Stock Forecast ( 2031 2032 - Meyka
Anbio Biotechnology (N3B.F) Stock Price, News, Quote & History - Yahoo
Anbio Biotechnology’s Hype And Hard Approvals Suggest A Stretched Valuation (NNNN) - Seeking Alpha
Anbio Biotechnology (N3B.F) Latest Press Releases & Corporate News - Yahoo
Page 795 - Laotian Times
Anbio Biotechnology prices $8M IPO at $5 per share - MSN
Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025 - digitalmore.co
Trump Sparks A 2025 IPO Boom: 5 New Stocks Have Rallied Over 400% - inkl
Anbio Biotechnology rises 40.5% - MSN
Anbio Biotechnology Class A Shares Take a Tumble - TipRanks
White Mountains Insurance, Rumble, Mesoblast And Other Big Stocks Moving Higher On Friday - Benzinga
Dow Jumps Over 200 Points; ISM Services PMI Falls In September - inkl
S&P 500 Futures Rise In Premarket Trading; Anbio Biotechnology, Rigetti Computing Lead - 富途牛牛
Anbio Biotechnology (NNNN) 재무 분석
Anbio Biotechnology (NNNN)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.51%
1.30%
자본화:
|
볼륨(24시간):